Ultrasound Examination and Guided Injection Into the Acromio-clavicular Joint

This study is not yet open for participant recruitment.
Verified June 2012 by The Baruch Padeh Medical Center, Poriya
Sponsor:
Information provided by (Responsible Party):
gordon edelson, The Baruch Padeh Medical Center, Poriya
ClinicalTrials.gov Identifier:
NCT01628796
First received: June 19, 2012
Last updated: June 26, 2012
Last verified: June 2012
  Purpose

Is it possible to improve the accuracy of injection into the acromio-clavicular joint with the use of ultrasound?


Condition Intervention
Osteoarthritis of Acromioclavicular Joint
Other: contrast material injection

Study Type: Interventional
Study Design: Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: Ultrasound Measurement of the Acromio-clavicular Joint and Injection of Standard Contrast Material Into the Joint Under Ultrasonic Control

Resource links provided by NLM:


Further study details as provided by The Baruch Padeh Medical Center, Poriya:

Primary Outcome Measures:
  • ultrasound controlled injection of contrast material into the AC joint followed by standard x-ray [ Time Frame: outcome assessed at the time of the injection (1 day) ] [ Designated as safety issue: No ]
    standard x-ray will be taken after the contrast dye has been injected into the joint to see whether it has successfully been placed into the joint.


Estimated Enrollment: 30
Study Start Date: July 2012
Estimated Study Completion Date: January 2013
Estimated Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)
Intervention Details:
    Other: contrast material injection
    using ultrasound to locate ac joint and injecting contrast material to ensure that the dye is actually in the joint
    Other Name: iomeron 350
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • adults over 18 years with AC joint degenerative changes
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01628796

Contacts
Contact: Gordon Edelson, MD 97246652670 edelson@bezeqint.net

Sponsors and Collaborators
The Baruch Padeh Medical Center, Poriya
  More Information

No publications provided

Responsible Party: gordon edelson, Professor of Orthopedic Surgery, The Baruch Padeh Medical Center, Poriya
ClinicalTrials.gov Identifier: NCT01628796     History of Changes
Other Study ID Numbers: 08-2012.CTIL
Study First Received: June 19, 2012
Last Updated: June 26, 2012
Health Authority: Israel: Ministry of Health

Additional relevant MeSH terms:
Osteoarthritis
Arthritis
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases

ClinicalTrials.gov processed this record on April 17, 2014